
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is expected to see opportunities in both the Greenfield and Brownfield categories, as many capped or limited fertility programs leave employees underserved. Additionally, the company's active management of a selective network of high-quality providers gives it a competitive edge. The recent quarterly results and management's guidance show strong performance and momentum, with potential for margin expansion driven by operating leverage.
Bears say
Progyny is currently facing concerns around potential shifts in market share and a reliance on market share gains rather than Greenfield opportunities, as well as potential impacts from the TrumpRx healthcare plan. While the company has a large and growing market opportunity and has seen consistent client retention and interest, there are lingering fears about unemployment affecting results and potential challenges in the upcoming selling season. Additionally, the company's guidance continues to assume conservative levels of utilization and consumption, potentially signaling a slower growth trajectory. As a result, caution is advised in investing in Progyny's stock.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares